Scholars Central

Research articlePublished 29 Jul 2022

Saccharomyces Cerevisiae for Abdominal Pain and Discomfort in Irritable Bowel Syndrome Patients

Authors: Mehreen Siyal

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Irritable Bowel Syndrome (IBS) leads to significant impairment of health related quality of life, for the alleviation of which, the efficacy of available therapies is modest. Limited data is available on the role of Saccharomyces cerevisiae in treating patients with IBS. Methods: 30 patients with IBS as per Rome-IV criteria, visiting our outpatient department from March 2021 to October 2021, were given capsule Saccharomyces cerevisiae 500 mg twice daily for four weeks. Evaluation for abdominal pain symptoms was done every week and the patient’s compliance was assessed. IBS Quality of Life (QOL) questionnaires were filled at baseline and after four weeks of treatment. The QOL and pain scales were adjusted to 0-100 for statistical analysis. Results: 17 patients (56.7%) were males. The age range was 21-72 years (mean ± SD: 39.63 ± 14.32), out of which 18 (60%) patients were 20-40 years old. BMI ranged from 18-33 (25.33 ± 4.09), and 17 (56.67%) were overweight or obese. 16 patients had constipation-predominant (53.3%), 9 had diarrhea-predominant (30%), and 5 had mixed-type (16.7%) IBS. There was an improvement in the pain score from 63.81 at W0 to 20.48 at the end of W4 (p<0.001). An improvement was noted in all the eight categories of IBS QOL questionnaire, i.e., dysphoria (p<0.001), interference with activity (p<0.001), body image (p<0.001), health worry (p<0.001), food avoidance (p<0.001), social reaction (p<0.001), sexual function (p<0.001) and relationships (p<0.001). There was an overall improvement in QOL score from a mean of 24.68 at baseline to 58.09 at the end of the study duration (p<0.001). The improvement in the pain score showed a positive correlation with the improvement in quality of life (p<0.001). Conclusions: Treatment with Saccharomyces cerevisiae improved the pain and quality of life in patients with IBS and it appears to be a promising option for alleviating symptoms in these patients.

Subjects

Microbiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Probiotics & Health.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Probiotics & Health
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Mehreen Siyal”